Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01286454 · ClinicalTrials.gov registry record · Phase 1
This Is A Study Of Bioavailability And Food Effect For Fesoterodine.
A Phase 1 study of Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01286454 is a Phase 1 study of Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency that has completed, run by Pfizer. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01286454, a Phase 1 study of Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This Is A Study Of Bioavailability And Food Effect For Fesoterodine.
Conditions Studied
Interventions
- DRUG fesoterodine
Study Locations (1)
Connecticut
- Pfizer Investigational Site - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-12 |
| Est. Completion | 2011-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01286454
The ClinicalTrials.gov registry entry for NCT01286454 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency appearing as the primary indexed condition, and to 1 intervention - of which fesoterodine is the first listed.
NCT01286454 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT01286454 about?
NCT01286454 is a clinical study titled "This Is A Study Of Bioavailability And Food Effect For Fesoterodine.". This Is A Study Of Bioavailability And Food Effect For Fesoterodine.
What is the current status of trial NCT01286454?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2010-12. Estimated completion is 2011-03.
What conditions does trial NCT01286454 study?
This clinical trial studies the following conditions: Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency.
What interventions are being tested in trial NCT01286454?
The interventions under investigation include: fesoterodine (DRUG).
Who is sponsoring clinical trial NCT01286454?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01286454 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.